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The  fatal  neurological  disease  occurring  in  adult  mice  injected  intracere- 
brally (IC) with lymphocytic choriomeningitis (LCM)  virus is apparently in- 
duced by massive invasion of leukocytes (1, 2) into the central nervous system 
(CNS). Dosing with antithymocyte serum or cyclophosphamide (2, 3) prevents 
cellular infiltration: mice survive as asymptomatic carriers. Adoptive induction 
of this inflammatory process, by injecting immune  spleen cells into immuno- 
suppressed recipients, depends on presence of specific thymus-derived lympho- 
cytes (T cells) in the transferred cell population (4). Such lymphocytes can now 
be  assayed  in  vitro  by  measuring  release  of  radioactivity from  51Cr-labeled 
target cells infected with LCM virus  (5,  6).  The present paper gives evidence 
that these cytotoxic T  cells are found in cerebrospinal fluid (CSF) of mice with 
clinical  LCM.  This  is,  to  our  knowledge,  the  first  direct  demonstration  of 
specifically sensitized lymphocytes in a  virus-induced inflammatory exudate. 
Materials and Methods 
Experimenlat.--8-10-wk old CBA/H male mice were injected IC with 300 mouse IC LDs0 
of the WE3 strain of LCM virus (1). This represents a  10  -5 dilution of infected guinea pig 
lung. Two experiments were done: (a) sequential development of cytotoxicity in spleen was 
assessed by inoculating groups of three animals each for 7 days. All mice were killed on the 
same day and activities of spleen cell suspensions  (7) were determined simultaneously in one 
assay; (b) 60 mice were injected with virus and killed, by ether anesthesia and exsanguination, 
when clinically affected 7 days later. Blood was defibrinated by rotation in the presence  of 
glass beads and leukocytes were separated (8) on a Ficoll (Pharmacia, Uppsala, Sweden) gra- 
dient. Spleens were removed  and samples of CSF were withdrawn from the cisterna magna 
(9), yielding 5-10 ttl (containing approximately 100,000 inflammatory cells) from each mouse. 
Cells from CSF were pooled, washed  once in 30.0 ml of medium  (see below), and pelletted. 
Aliquots were treated with AKR anti-0 ascitic fluid, or normal AKR ascitic fluid, and agarose 
absorbed guinea pig complement  (7). Cell viability  was determined by Trypan blue exclusion. 
All counts cited are for viable cells, viability of untreated cells from all sources being invari- 
ably greater than 85%. 
51Cr Release  Assay.--The medium used throughout was Eagle's minimal essential medium 
plus nonessential  amino  acid (F15,  Grand Island Biochemical  Co.,  Grand  Island, N. Y.) 
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incorporating, except for dilution of 51Cr, 10% heat inactivated fetal calf serum. Monolayers 
of L929 cells (L cells) were grown in flat bottomed plastic tissue culture trays (Linbro Chemical 
Co., New Haven, Conn.). Two types were used, one with a well diameter of 16 mm (3 X  105 
target cells) and the other of 6 mm (4 X  104 target cells). Use of the 6 mm wells was neces- 
sitated by the small numbers of cells obtained from CSF. Target cells were grown for 24 h, 
infected with a high dose (1.5  X  10 ~ LDs0) of WE3 LCM virus in guinea pig spleen suspen- 
sion, and labeled with 2 gCi of 51Cr (C. A. E., Gif-sur Yvette, France) after a  further 24 h. 
Control monolayers were either left uninfected, or infected with 5 X  107 PFU of the Moscow 
strain of ectromelia virus at 6 h after labeling. 1 All monolayers were washed thoroughly (four 
times) to remove excess 51Cr and layered with the cell suspension to be tested, dispensed in 
either 1.5 ml or 0.3 ml of medium. Assays were incubated for 17 h  at 37°C in an atmosphere 
of 10% CO2 and 7% O2 in N~. Supernates were then gently aspirated and monolayers were 
lysed with water. Percent of 51Cr release was determined as,  (Counts in supernate X  100)/ 
(Counts in supernate +  counts in water lysate). This value was corrected by a factor of 100/75, 
which takes into account that the mean amount of label maximally released by water lysis of 
infected target cells is 75%. 
RESULTS  AND  DISCUSSION 
Only a small proportion of an IC inoculum (< 10 %) remains in the CNS (10). 
The majority of virus injected escapes directly into the blood. Splenic lymphoid 
tissue should thus be rapidly exposed to viral antigen, the initial low dose being 
greatly reinforced by viral replication within the organ (1). Significant cytotoxic 
activity was first detected in spleen at 6 days after inoculation and reached a 
very high level by the following day (Fig. 1), when all mice showed obvious signs 
of neurological impairment. Onset of symptoms thus parallels development of 
cytotoxic cells in lymphoid tissue. 
CSF from clinically affected mice contained cells which were cytotoxic for L 
cells infected with LCM virus (Table I). Activity was destroyed by treatment 
with AKR anti-0 ascitic fluid and complement (which killed 60% of cells),  but 
not by normal AKR ascitic fluid and complement.  Release of 51Cr was  ap- 
parently due to presence of activated thymus-derived lymphocytes. These T 
cells are specific (Table II) insofar as they had no activity against either normal 
L  cells  or L  cells  infected with ectromelia virus, which are readily lysed by 
lymphocytes from ectromelia immune mice.  1 
Presumably cytotoxic T  cells are generated in spleen  2 and circulate in blood 
(Table II). At least some of these lymphocytes localize in the CSF. Many more 
sensitized cells probably enter other organs e.g., lung and liver (11). Cell popu- 
lations from CSF exhibit greater cytotoxic activity than do blood leukocytes 
(Table I), an indication that specifically committed lymphocytes may be con- 
centrated in the inflammatory exudate. Also, the minimal contamination with 
blood (<5 %)  that may occur during sampling (9)  would have no significant 
effect on activity of CSF cells. 
1 Gardner, I., N. A. Bowern, and R. V. Blanden. Cell-mediated cytotoxicity against ectro- 
melia virus-infected target cells.  I. Specificity and kinetics. Manuscript in preparation. 
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Fro. 1. Sequential development of cytotoxic activity in spleens from mice injected IC with 
300 LDs0 of WE3 LCM virus. Spleen suspensions were assayed on 3 X  105 target L cells in- 
fected with LCM virus. Levels of 51Cr release by immune cells were significantly greater than 
those caused by normal spleen cells on days 6 (P (0.01) and 7 (P <  0.001), for 1 X  107 cells, 
and day 7 (P <  0.001) for 3 X  106 cells. 
TABLE  I 
Cytotoxic Activity of 1.5 X  105 Viable CeUs  for 4 X  104 Target L Cells Infected with LCM Virus 
Source  Inoculum  Treatment  %6*Cr release  P  values 
CSF 
Blood 
Spleen 
LCM  Nil  49.0  -4-  0.5 
<0.001 
LCM  Anti-0*  27.7  4-  1.3 
<0.001 
LCM  N aseitic*  43.7  4-  0.5 
LCM  Nil  36.5  4-  1.15 
LCM  Nil  41.2  q-  1.5 
<0.01 
Nil  Nil  29.5  ztz  0.8 
* Treated with AKR anti-0 ascitic fluid  and complement, or normal AKR ascitic fluid 
and complement. 
:~ This value is not significantly different from background release caused by  1.5  X  106 
blood cells (Table II). 
TABLE  II 
Specificity of Cytotoxic  Cells 
Cells  %51Cr release from 4  X  104 L  cells 
Source  Inoculum  No.  LCM  Ectromelia  Normal 
CSF  LCM  1.5  X  105  49.0  -4-  0.5*  22.5  :k  0.4  24.5  4.  1.1 
Blood  LCM  1.5  X  106  68.2  ±  1.1"  --  36.1  4-  1.1:~ 
Spleen  LCM  1.5  X  106  56.7  4-  0.5*  19.0  :i:  0.3  22.5  =k  0.7 
Nil  1.5  X  106  23.7  4-  0.5  --  -- 
* Significantly greater (P <  0.001) than release from normal targets, or by control spleen 
cells on infected targets. 
:~ This high release from normal targets may be due to presence of large numbers of con- 
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Most virus in CNS is localized, by immunofluorescence, in cells of the choroid 
plexus, ependyma, and meninges (2). Direct cell-mediated damage to cells ex- 
pressing LCM viral antigen would offer some explanation for the pathogenesis 
of acute LCM  (1). There is, however, no  rigorous proof that such a  process 
occurs in viva. 
The  data  presented  here  support  the  following  conclusions:  (a)  sensitized 
thymus-derived lymphocytes are invasive; (b) capacity to release 51Cr in vitro 
is not conferred on non-0-bearing cells in the inflammatory exudate;  (c)  cyto- 
toxic potential is not readily exhausted, either by the process of entry into CSF 
or by the large amounts of viral antigen present in cells lining the CSF spaces 
(2). 
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